首页 > 最新文献

Journal of Investigative Surgery最新文献

英文 中文
Effectiveness Analysis of Sevoflurane Combined with Propofol or Remimazolam Anesthesia in Pediatric Laparoscopic Inguinal Hernia Repair and Its Impact on Hemodynamics and Postoperative Pain. 七氟醚联合异丙酚或雷马唑仑麻醉在小儿腹腔镜腹股沟疝修补术中的疗效分析及对血流动力学和术后疼痛的影响。
IF 2.1 4区 医学 Q2 SURGERY Pub Date : 2025-12-01 Epub Date: 2025-06-12 DOI: 10.1080/08941939.2025.2500438
Renqi Liu, Zhiyi Wang, Yuanyuan Meng, Weiye Chen, Min Zhou

Purpose: This study evaluated the clinical effectiveness of combined treatment of sevoflurane with propofol or remimazolam in decreasing hemodynamic changes and postoperative pain in pediatric patients undergoing laparoscopic inguinal hernia repair (LIHR).

Methods: This study prospectively recruited 287 children with hernia admitted to our hospital from September 2020 to October 2023. These children were allocated into the sevoflurane plus remimazolam and sevoflurane plus propofol groups using the random number table method. General clinical data at admission were collected. Clinical outcomes were compared between the two groups. The primary outcomes included anesthesia quality, intraoperative hemodynamic indicators at different time points (MAP, SpO2, HR), and the postoperative FLACC score, while the secondary outcomes included the PAED score of the children and the incidence of postoperative adverse reactions.

Results: No remarkable difference occurred between these two groups regarding general clinical data. Compared to the sevoflurane plus propofol group, the sevoflurane plus remimazolam group resulted in significantly lower MAP and HR at T1, T2, T3, and T4 (p < .05), shorter postoperative awakening time (mean difference: 2.9 min, p < .01), lower FLACC pain scores at 0.5, 1, and 2 h postoperatively (p < .05), and lower PAED scores at 5, 15, and 30 min postoperatively (p < .05). Adverse effects were lower in the sevoflurane + remimazolam group (5% vs. 12%, p = .076).

Conclusion: Sevoflurane plus remimazolam in children receiving LIHR has minimal impact on hemodynamics, reduces pain levels within 4 h postoperatively, lowers PAED and agitation scores, and demonstrates high safety.

目的:本研究评价七氟醚联合异丙酚或雷马唑仑治疗小儿腹腔镜腹股沟疝修补术(LIHR)患者血流动力学改变和术后疼痛的临床效果。方法:本研究前瞻性招募2020年9月至2023年10月在我院住院的287例疝患儿。采用随机数字表法将这些儿童分为七氟醚加雷马唑仑组和七氟醚加异丙酚组。收集入院时的一般临床资料。比较两组患者的临床结果。主要结局包括麻醉质量、术中不同时间点血流动力学指标(MAP、SpO2、HR)及术后FLACC评分,次要结局包括患儿PAED评分及术后不良反应发生率。结果:两组一般临床资料无显著差异。与七氟醚加异丙酚组相比,七氟醚加雷马唑仑组在T1、T2、T3和T4时MAP和HR显著降低(p p p p p = 0.076)。结论:七氟醚加雷马唑仑对LIHR患儿血流动力学影响最小,术后4 h内疼痛水平降低,PAED和躁动评分降低,安全性高。
{"title":"Effectiveness Analysis of Sevoflurane Combined with Propofol or Remimazolam Anesthesia in Pediatric Laparoscopic Inguinal Hernia Repair and Its Impact on Hemodynamics and Postoperative Pain.","authors":"Renqi Liu, Zhiyi Wang, Yuanyuan Meng, Weiye Chen, Min Zhou","doi":"10.1080/08941939.2025.2500438","DOIUrl":"10.1080/08941939.2025.2500438","url":null,"abstract":"<p><strong>Purpose: </strong>This study evaluated the clinical effectiveness of combined treatment of sevoflurane with propofol or remimazolam in decreasing hemodynamic changes and postoperative pain in pediatric patients undergoing laparoscopic inguinal hernia repair (LIHR).</p><p><strong>Methods: </strong>This study prospectively recruited 287 children with hernia admitted to our hospital from September 2020 to October 2023. These children were allocated into the sevoflurane plus remimazolam and sevoflurane plus propofol groups using the random number table method. General clinical data at admission were collected. Clinical outcomes were compared between the two groups. The primary outcomes included anesthesia quality, intraoperative hemodynamic indicators at different time points (MAP, SpO<sub>2</sub>, HR), and the postoperative FLACC score, while the secondary outcomes included the PAED score of the children and the incidence of postoperative adverse reactions.</p><p><strong>Results: </strong>No remarkable difference occurred between these two groups regarding general clinical data. Compared to the sevoflurane plus propofol group, the sevoflurane plus remimazolam group resulted in significantly lower MAP and HR at T1, T2, T3, and T4 (<i>p</i> < .05), shorter postoperative awakening time (mean difference: 2.9 min, <i>p</i> < .01), lower FLACC pain scores at 0.5, 1, and 2 h postoperatively (<i>p</i> < .05), and lower PAED scores at 5, 15, and 30 min postoperatively (<i>p</i> < .05). Adverse effects were lower in the sevoflurane + remimazolam group (5% vs. 12%, <i>p</i> = .076).</p><p><strong>Conclusion: </strong>Sevoflurane plus remimazolam in children receiving LIHR has minimal impact on hemodynamics, reduces pain levels within 4 h postoperatively, lowers PAED and agitation scores, and demonstrates high safety.</p>","PeriodicalId":16200,"journal":{"name":"Journal of Investigative Surgery","volume":"38 1","pages":"2500438"},"PeriodicalIF":2.1,"publicationDate":"2025-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144284941","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
An Epidemiological Study on Survival in Lymphoma of Mucosa-Associated Lymphoid Tissue: A Comparative Analysis by Primary Tumor Location. 粘膜相关淋巴组织淋巴瘤生存的流行病学研究:原发肿瘤部位的比较分析。
IF 2.1 4区 医学 Q2 SURGERY Pub Date : 2025-12-01 Epub Date: 2025-06-30 DOI: 10.1080/08941939.2025.2523858
Gui-Ping Chen, Zhen-Zhen Lu, Guan-Zhong Lu, Yi Zhou, San-Gang Wu

Purpose: To investigate outcome and local treatment strategy for extranodal mucosa-associated lymphoid tissue (MALT) lymphoma patients.

Methods: Retrospectively collected patients using the data from the Surveillance, Epidemiology, and End Results database, including tumor sites with over 200 cases.

Results: The cohort comprised 3842 patients, with the gastric region being the most prevalent site (34.9%), followed by salivary gland (16.8%), cutaneous (16.5%), pulmonary (13.3%), intestinal (13.2%), and head and neck (5.4%). The 10-year cancer-specific survival (CSS) was 88.1%, 92.6%, 86.5%, 87.7%, 89.7%, and 97.7% in patients with tumors located in the gastric, salivary gland, pulmonary, head and neck, intestinal, and cutaneous, respectively (p < 0.001). Compared to gastric MALT lymphoma, the cutaneous site exhibited superior CSS (p < 0.001), whereas other sites showed comparable outcomes (all p ≥ 0.05). In gastric MALT lymphoma cases, radiotherapy was associated with better CSS than surgery alone (p < 0.001), while no significant difference was observed between surgery plus radiotherapy versus surgery alone (p = 0.561). Treatment outcomes were similar across the three therapeutic modalities for non-gastric sites.

Conclusions: Our findings underscore the biological and clinical heterogeneity of extranodal MALT lymphoma. While localized treatments provide equivalent results across most non-gastric sites, radiotherapy is recommended as the primary noninvasive treatment option.

目的:探讨结外粘膜相关淋巴组织(MALT)淋巴瘤患者的预后和局部治疗策略。方法:回顾性收集来自监测、流行病学和最终结果数据库的数据,包括200多例肿瘤部位的患者。结果:该队列共3842例患者,胃区是最常见的部位(34.9%),其次是唾液腺(16.8%)、皮肤(16.5%)、肺部(13.3%)、肠道(13.2%)和头颈部(5.4%)。肿瘤位于胃、唾液腺、肺、头颈部、肠道和皮肤的10年肿瘤特异性生存率(CSS)分别为88.1%、92.6%、86.5%、87.7%、89.7%和97.7% (p < 0.001)。与胃MALT淋巴瘤相比,皮肤部位表现出更好的CSS (p p≥0.05)。在胃MALT淋巴瘤病例中,放疗比单纯手术有更好的CSS (p p = 0.561)。非胃部位的三种治疗方式的治疗结果相似。结论:我们的研究结果强调结外MALT淋巴瘤的生物学和临床异质性。虽然局部治疗在大多数非胃部位提供相同的结果,但推荐放疗作为主要的非侵入性治疗选择。
{"title":"An Epidemiological Study on Survival in Lymphoma of Mucosa-Associated Lymphoid Tissue: A Comparative Analysis by Primary Tumor Location.","authors":"Gui-Ping Chen, Zhen-Zhen Lu, Guan-Zhong Lu, Yi Zhou, San-Gang Wu","doi":"10.1080/08941939.2025.2523858","DOIUrl":"https://doi.org/10.1080/08941939.2025.2523858","url":null,"abstract":"<p><strong>Purpose: </strong>To investigate outcome and local treatment strategy for extranodal mucosa-associated lymphoid tissue (MALT) lymphoma patients.</p><p><strong>Methods: </strong>Retrospectively collected patients using the data from the Surveillance, Epidemiology, and End Results database, including tumor sites with over 200 cases.</p><p><strong>Results: </strong>The cohort comprised 3842 patients, with the gastric region being the most prevalent site (34.9%), followed by salivary gland (16.8%), cutaneous (16.5%), pulmonary (13.3%), intestinal (13.2%), and head and neck (5.4%). The 10-year cancer-specific survival (CSS) was 88.1%, 92.6%, 86.5%, 87.7%, 89.7%, and 97.7% in patients with tumors located in the gastric, salivary gland, pulmonary, head and neck, intestinal, and cutaneous, respectively (<i>p</i> < 0.001). Compared to gastric MALT lymphoma, the cutaneous site exhibited superior CSS (<i>p</i> < 0.001), whereas other sites showed comparable outcomes (all <i>p</i> ≥ 0.05). In gastric MALT lymphoma cases, radiotherapy was associated with better CSS than surgery alone (<i>p</i> < 0.001), while no significant difference was observed between surgery plus radiotherapy versus surgery alone (<i>p</i> = 0.561). Treatment outcomes were similar across the three therapeutic modalities for non-gastric sites.</p><p><strong>Conclusions: </strong>Our findings underscore the biological and clinical heterogeneity of extranodal MALT lymphoma. While localized treatments provide equivalent results across most non-gastric sites, radiotherapy is recommended as the primary noninvasive treatment option.</p>","PeriodicalId":16200,"journal":{"name":"Journal of Investigative Surgery","volume":"38 1","pages":"2523858"},"PeriodicalIF":2.1,"publicationDate":"2025-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144528352","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Effect of Prior Bariatric Surgery on the Outcomes of Joint Arthroplasty: A Systematic Review and Meta-Analysis. 既往减肥手术对关节成形术结果的影响:系统回顾和荟萃分析。
IF 3.5 4区 医学 Q2 SURGERY Pub Date : 2025-12-01 Epub Date: 2025-01-08 DOI: 10.1080/08941939.2024.2446579
Zhou Zhang, Xiang Shi, Wei Liu, Jianwei Wang, Qingfeng Shen, Guozhu Xu, Jiakuan Bao, Yupeng Dong

Objective: Obesity is a risk factor for joint arthroplasty complications. With this systematic review and meta-analysis, we assessed whether a positive history of bariatric surgery influences postoperative outcomes in patients undergoing various types of joint arthroplasty.

Methods: We conducted a comprehensive search database such as Scopus, PubMed, Medline Ovid, CNKI, and CENTRAL for studies comparing outcomes between patients undergoing arthroplasty with and without a history of bariatric surgery. We extracted data on short-term medical complications, venous thromboembolism (VTE), periprosthetic infections, superficial wound infections, hospital stay length, and operative time. We used the data to conduct meta-analyses using random-effects models and subgroup analyses based on the type of arthroplasty.

Results: Overall, 15 studies with nearly 150,000 participants were included. The analysis showed that prior bariatric surgery did not significantly affect overall medical complications post-arthroplasty, with OR of 0.968 (95%CI, 0.706-1.327). For VTE, the results similarly indicated no substantial difference, with an OR of 0.912 (95%CI, 0.644-1.291). In assessing periprosthetic infections, the OR was 0.754 (95%CI, 0.535-1.064), showing comparable rates between patients with and without a history of bariatric surgery.Regarding superficial wound infections, the analysis produced an OR of 2.390 (95%CI, 0.723-7.897), indicating variability but not statistical significance. Hospital stay length was reduced in patients with a history of bariatric surgery, reflected by SMD of -0.113 (95%CI, -0.221 to -0.005). Lastly, operative time also showed a significant reduction, with an SMD of -0.462 (95%CI, -0.865 to -0.059).

Conclusions: Prior bariatric surgery does not reduce the risk of short-term complications post-arthroplasty, but it seems to reduce the hospital stay length and operative time. The effects vary significantly across different types of joint arthroplasty, suggesting a need for tailored preoperative assessments and care protocols.

Protocol registration: This systematic review and meta-analysis was registered at PROSPERO, with the number: CRD42024539052.

目的:肥胖是关节置换术并发症的危险因素。通过这一系统综述和荟萃分析,我们评估了积极的减肥手术史是否会影响接受各种类型关节置换术的患者的术后结果。方法:我们对Scopus、PubMed、Medline Ovid、CNKI和CENTRAL等数据库进行了全面的检索,比较有和没有减肥手术史的关节置换术患者的结果。我们提取了短期医疗并发症、静脉血栓栓塞(VTE)、假体周围感染、浅表伤口感染、住院时间和手术时间的数据。我们使用随机效应模型和基于关节置换类型的亚组分析对数据进行meta分析。结果:总共纳入了15项研究,近15万名参与者。分析显示,先前的减肥手术对关节置换术后的总体医疗并发症没有显著影响,OR为0.968 (95%CI, 0.706-1.327)。对于静脉血栓栓塞,结果同样显示无显著差异,OR为0.912 (95%CI, 0.644-1.291)。在评估假体周围感染时,OR为0.754 (95%CI, 0.535-1.064),显示有和没有减肥手术史的患者之间的发生率相当。对于浅表伤口感染,分析产生的OR为2.390 (95%CI, 0.723-7.897),表明存在变异性,但无统计学意义。有减肥手术史的患者住院时间缩短,SMD为-0.113 (95%CI, -0.221至-0.005)。最后,手术时间也显着减少,SMD为-0.462 (95%CI, -0.865至-0.059)。结论:先前的减肥手术并不能降低关节置换术后短期并发症的风险,但似乎可以减少住院时间和手术时间。不同类型的关节置换术的效果差异很大,这表明需要量身定制的术前评估和护理方案。方案注册:该系统评价和荟萃分析在PROSPERO注册,编号:CRD42024539052。
{"title":"Effect of Prior Bariatric Surgery on the Outcomes of Joint Arthroplasty: A Systematic Review and Meta-Analysis.","authors":"Zhou Zhang, Xiang Shi, Wei Liu, Jianwei Wang, Qingfeng Shen, Guozhu Xu, Jiakuan Bao, Yupeng Dong","doi":"10.1080/08941939.2024.2446579","DOIUrl":"10.1080/08941939.2024.2446579","url":null,"abstract":"<p><strong>Objective: </strong>Obesity is a risk factor for joint arthroplasty complications. With this systematic review and meta-analysis, we assessed whether a positive history of bariatric surgery influences postoperative outcomes in patients undergoing various types of joint arthroplasty.</p><p><strong>Methods: </strong>We conducted a comprehensive search database such as Scopus, PubMed, Medline Ovid, CNKI, and CENTRAL for studies comparing outcomes between patients undergoing arthroplasty with and without a history of bariatric surgery. We extracted data on short-term medical complications, venous thromboembolism (VTE), periprosthetic infections, superficial wound infections, hospital stay length, and operative time. We used the data to conduct meta-analyses using random-effects models and subgroup analyses based on the type of arthroplasty.</p><p><strong>Results: </strong>Overall, 15 studies with nearly 150,000 participants were included. The analysis showed that prior bariatric surgery did not significantly affect overall medical complications post-arthroplasty, with OR of 0.968 (95%CI, 0.706-1.327). For VTE, the results similarly indicated no substantial difference, with an OR of 0.912 (95%CI, 0.644-1.291). In assessing periprosthetic infections, the OR was 0.754 (95%CI, 0.535-1.064), showing comparable rates between patients with and without a history of bariatric surgery.Regarding superficial wound infections, the analysis produced an OR of 2.390 (95%CI, 0.723-7.897), indicating variability but not statistical significance. Hospital stay length was reduced in patients with a history of bariatric surgery, reflected by SMD of -0.113 (95%CI, -0.221 to -0.005). Lastly, operative time also showed a significant reduction, with an SMD of -0.462 (95%CI, -0.865 to -0.059).</p><p><strong>Conclusions: </strong>Prior bariatric surgery does not reduce the risk of short-term complications post-arthroplasty, but it seems to reduce the hospital stay length and operative time. The effects vary significantly across different types of joint arthroplasty, suggesting a need for tailored preoperative assessments and care protocols.</p><p><strong>Protocol registration: </strong>This systematic review and meta-analysis was registered at PROSPERO, with the number: CRD42024539052.</p>","PeriodicalId":16200,"journal":{"name":"Journal of Investigative Surgery","volume":"38 1","pages":"2446579"},"PeriodicalIF":3.5,"publicationDate":"2025-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142950210","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Effect of Co-Administration of Midazolam and Dexmedetomidine on Haemodynamics and Stress Response in Elderly Patients with Non-Small Cell Lung Cancer. 咪达唑仑与右美托咪定联用对老年非小细胞肺癌患者血流动力学和应激反应的影响。
IF 2.1 4区 医学 Q2 SURGERY Pub Date : 2025-12-01 Epub Date: 2025-01-05 DOI: 10.1080/08941939.2024.2445587
Yanjun Zhao, Dongjiao An, Liang Bi
<p><strong>Objective: </strong>This study aimed to evaluate the effect of co-administration of midazolam and dexmedetomidine on hemodynamics and stress response in elderly patients with non-small cell lung cancer (NSCLC).</p><p><strong>Methods: </strong>In this prospective, randomized controlled trial, 154 elderly NSCLC patients scheduled for lobectomy in our oncology department from January 2019 to December 2021 were recruited. Patients were randomized 1:1 to receive either dexmedetomidine (control group) or dexmedetomidine plus midazolam (study group) for anesthesia during lobectomy <i>via</i> the random number table method, with 77 patients in each group. Perioperative indicators, hemodynamics, and stress reactions of the patients were recorded and compared between the two groups to investigate the efficacy of the two different anesthetic protocols.</p><p><strong>Results: </strong>No significant differences were observed between the two groups in terms of operative time, anesthesia time, and intraoperative bleeding volume (<i>p</i> > 0.05). Preoperative pain, pain at anesthesia recovery, and pain levels 7 days postoperatively were also comparable between the two groups. In the study group, the awakening time was 15 ± 2 min significantly shorter compared to the control group (25 ± 3 min). Cooperation within the first hour was significantly faster by 8.5 ± 0.5 min compared to 6.0 ± 1.0 min in the control group (<i>p</i> < 0.05). The cost of materials used was significantly higher in the study group, with an average of 300 ± 25 USD, compared to 200 ± 20 USD in the control group (<i>p</i> < 0.05). Additionally, the two groups showed no significant difference in the need for experience and surveillance (<i>p</i> > 0.05). Significantly lower visual analog scale (VAS) scores were found one day after the surgery in patients given dexmedetomidine plus midazolam than those anesthetized administered with dexmedetomidine only, suggesting an enhanced pain mitigation effect after incorporating midazolam for anesthetic induction. Patients treated with dexmedetomidine plus midazolam presented with a more stable hemodynamic status than those treated with dexmedetomidine only, as evidenced by the significantly lower variability of mean arterial pressure (MAP), oxygen saturation (SpO2), and heart rate (HR). Co-administration of dexmedetomidine plus midazolam for lobectomy anesthesia resulted in significantly lower serum cortisol (Cor) and norepinephrine (NE) concentrations in patients at anesthesia recovery than dexmedetomidine alone. However, this difference was not observed one day postoperatively. There was no statistically significant difference in the incidence of adverse reactions between the two groups.</p><p><strong>Conclusion: </strong>The combination of midazolam with dexmedetomidine anesthesia in lobectomy improves the intraoperative hemodynamic status of elderly patients with NSCLC and mitigates their stress response. However, further research is req
目的:探讨咪达唑仑与右美托咪定合用对老年非小细胞肺癌(NSCLC)患者血流动力学和应激反应的影响。方法:在这项前瞻性随机对照试验中,招募了2019年1月至2021年12月在我院肿瘤科计划行肺叶切除术的154例老年非小细胞肺癌患者。采用随机数字表法,将患者1:1随机分为右美托咪定(对照组)和右美托咪定加咪达唑仑(研究组)两组,每组77例。记录两组患者围手术期指标、血流动力学和应激反应,比较两组患者不同麻醉方案的疗效。结果:两组手术时间、麻醉时间、术中出血量比较,差异均无统计学意义(p < 0.05)。两组患者术前疼痛、麻醉恢复时疼痛和术后7天疼痛水平也具有可比性。研究组苏醒时间为15±2 min,明显短于对照组(25±3 min)。第1 h内合作时间比对照组的6.0±1.0 min快8.5±0.5 min (p p p > 0.05)。术后1天给予右美托咪定联合咪达唑仑的患者视觉模拟评分(VAS)明显低于仅给予右美托咪定麻醉的患者,提示咪达唑仑麻醉诱导后疼痛缓解效果增强。右美托咪定联合咪达唑仑治疗的患者血流动力学状态比单用右美托咪定治疗的患者更稳定,平均动脉压(MAP)、血氧饱和度(SpO2)和心率(HR)的变异性显著降低。右美托咪定联合咪达唑仑用于肺叶切除术麻醉,麻醉恢复时患者血清皮质醇(Cor)和去甲肾上腺素(NE)浓度明显低于单用右美托咪定。然而,术后1天未观察到这种差异。两组患者不良反应发生率比较,差异无统计学意义。结论:咪达唑仑联合右美托咪定麻醉在肺叶切除术中可改善老年NSCLC患者术中血流动力学状态,减轻其应激反应。然而,需要进一步的研究来探索潜在的机制。
{"title":"Effect of Co-Administration of Midazolam and Dexmedetomidine on Haemodynamics and Stress Response in Elderly Patients with Non-Small Cell Lung Cancer.","authors":"Yanjun Zhao, Dongjiao An, Liang Bi","doi":"10.1080/08941939.2024.2445587","DOIUrl":"https://doi.org/10.1080/08941939.2024.2445587","url":null,"abstract":"&lt;p&gt;&lt;strong&gt;Objective: &lt;/strong&gt;This study aimed to evaluate the effect of co-administration of midazolam and dexmedetomidine on hemodynamics and stress response in elderly patients with non-small cell lung cancer (NSCLC).&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Methods: &lt;/strong&gt;In this prospective, randomized controlled trial, 154 elderly NSCLC patients scheduled for lobectomy in our oncology department from January 2019 to December 2021 were recruited. Patients were randomized 1:1 to receive either dexmedetomidine (control group) or dexmedetomidine plus midazolam (study group) for anesthesia during lobectomy &lt;i&gt;via&lt;/i&gt; the random number table method, with 77 patients in each group. Perioperative indicators, hemodynamics, and stress reactions of the patients were recorded and compared between the two groups to investigate the efficacy of the two different anesthetic protocols.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Results: &lt;/strong&gt;No significant differences were observed between the two groups in terms of operative time, anesthesia time, and intraoperative bleeding volume (&lt;i&gt;p&lt;/i&gt; &gt; 0.05). Preoperative pain, pain at anesthesia recovery, and pain levels 7 days postoperatively were also comparable between the two groups. In the study group, the awakening time was 15 ± 2 min significantly shorter compared to the control group (25 ± 3 min). Cooperation within the first hour was significantly faster by 8.5 ± 0.5 min compared to 6.0 ± 1.0 min in the control group (&lt;i&gt;p&lt;/i&gt; &lt; 0.05). The cost of materials used was significantly higher in the study group, with an average of 300 ± 25 USD, compared to 200 ± 20 USD in the control group (&lt;i&gt;p&lt;/i&gt; &lt; 0.05). Additionally, the two groups showed no significant difference in the need for experience and surveillance (&lt;i&gt;p&lt;/i&gt; &gt; 0.05). Significantly lower visual analog scale (VAS) scores were found one day after the surgery in patients given dexmedetomidine plus midazolam than those anesthetized administered with dexmedetomidine only, suggesting an enhanced pain mitigation effect after incorporating midazolam for anesthetic induction. Patients treated with dexmedetomidine plus midazolam presented with a more stable hemodynamic status than those treated with dexmedetomidine only, as evidenced by the significantly lower variability of mean arterial pressure (MAP), oxygen saturation (SpO2), and heart rate (HR). Co-administration of dexmedetomidine plus midazolam for lobectomy anesthesia resulted in significantly lower serum cortisol (Cor) and norepinephrine (NE) concentrations in patients at anesthesia recovery than dexmedetomidine alone. However, this difference was not observed one day postoperatively. There was no statistically significant difference in the incidence of adverse reactions between the two groups.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Conclusion: &lt;/strong&gt;The combination of midazolam with dexmedetomidine anesthesia in lobectomy improves the intraoperative hemodynamic status of elderly patients with NSCLC and mitigates their stress response. However, further research is req","PeriodicalId":16200,"journal":{"name":"Journal of Investigative Surgery","volume":"38 1","pages":"2445587"},"PeriodicalIF":2.1,"publicationDate":"2025-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142932030","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Feasibility and Prognostic Analysis of Neoadjuvant Therapy Followed by Breast-Conserving Surgery for Invasive Ductal Carcinoma Combined with Ductal Carcinoma in Situ. 浸润性导管癌合并导管原位癌新辅助治疗后保乳手术的可行性及预后分析。
IF 3.5 4区 医学 Q2 SURGERY Pub Date : 2025-12-01 Epub Date: 2025-09-01 DOI: 10.1080/08941939.2025.2547226
Sicheng Zhou, Hongyu Xiang, Zehao Huang, Yue Teng, Wei Xing

Objective: This study aim to investigate the oncological safety of neoadjuvant therapy (NAT) followed by breast-conserving surgery (BCS) for invasive ductal carcinoma (IDC) patients with the presence of ductal carcinoma in situ (DCIS) on pre-NAT biopsy.

Methods: The data of women with IDC who underwent radical surgery between January 2013 and December 2021 were retrospectively reviewed from two institutions. The study endpoints were 5-year disease-free survival (DFS) and local recurrence-fee survival (LRFS).

Results: Overall, 994 eligible patients were enrolled. Patients with IDC with DCIS (n = 277) and patients undergoing BCS (n = 285) were selected separately for prognostic analysis. For patients with IDC with DCIS, the 5-year DFS (p = 0.517) and 5-year LRFS (p = 0.397) rates of the patients undergoing BCS were similar to those of patients undergoing mastectomy after propensity score matching. In addition, the 285 patients who underwent BCS were divided into the IDC + DCIS and IDC groups. The 5-year DFS (p = 0.394) and 5-year LRFS (p = 0.341) rates were similar between the IDC and IDC + DCIS groups.

Conclusion: NAT followed by BCS combined with adjuvant radiotherapy is a safe and feasible treatment option in patients with IDC with DCIS under the premise of strict adherence to the surgical indications and adequate incision margins.

目的:探讨新辅助治疗(NAT)后保乳手术(BCS)对浸润性导管癌(IDC)术前活检存在导管原位癌(DCIS)患者的肿瘤学安全性。方法:回顾性分析两家机构2013年1月至2021年12月间行根治性手术的女性IDC患者的资料。研究终点为5年无病生存(DFS)和局部复发费生存(LRFS)。结果:共纳入994例符合条件的患者。分别选择IDC合并DCIS患者(n = 277)和BCS患者(n = 285)进行预后分析。对于IDC合并DCIS患者,经倾向评分匹配后,行BCS患者的5年DFS (p = 0.517)和5年LRFS (p = 0.397)率与行乳腺切除术患者相似。将285例行BCS的患者分为IDC + DCIS组和IDC组。IDC组和IDC + DCIS组的5年DFS (p = 0.394)和5年LRFS (p = 0.341)相似。结论:在严格遵守手术指征和适当切缘的前提下,NAT + BCS +辅助放疗是IDC合并DCIS患者安全可行的治疗方案。
{"title":"Feasibility and Prognostic Analysis of Neoadjuvant Therapy Followed by Breast-Conserving Surgery for Invasive Ductal Carcinoma Combined with Ductal Carcinoma in Situ.","authors":"Sicheng Zhou, Hongyu Xiang, Zehao Huang, Yue Teng, Wei Xing","doi":"10.1080/08941939.2025.2547226","DOIUrl":"10.1080/08941939.2025.2547226","url":null,"abstract":"<p><strong>Objective: </strong>This study aim to investigate the oncological safety of neoadjuvant therapy (NAT) followed by breast-conserving surgery (BCS) for invasive ductal carcinoma (IDC) patients with the presence of ductal carcinoma <i>in situ</i> (DCIS) on pre-NAT biopsy.</p><p><strong>Methods: </strong>The data of women with IDC who underwent radical surgery between January 2013 and December 2021 were retrospectively reviewed from two institutions. The study endpoints were 5-year disease-free survival (DFS) and local recurrence-fee survival (LRFS).</p><p><strong>Results: </strong>Overall, 994 eligible patients were enrolled. Patients with IDC with DCIS (<i>n</i> = 277) and patients undergoing BCS (<i>n</i> = 285) were selected separately for prognostic analysis. For patients with IDC with DCIS, the 5-year DFS (<i>p</i> = 0.517) and 5-year LRFS (<i>p</i> = 0.397) rates of the patients undergoing BCS were similar to those of patients undergoing mastectomy after propensity score matching. In addition, the 285 patients who underwent BCS were divided into the IDC + DCIS and IDC groups. The 5-year DFS (<i>p</i> = 0.394) and 5-year LRFS (<i>p</i> = 0.341) rates were similar between the IDC and IDC + DCIS groups.</p><p><strong>Conclusion: </strong>NAT followed by BCS combined with adjuvant radiotherapy is a safe and feasible treatment option in patients with IDC with DCIS under the premise of strict adherence to the surgical indications and adequate incision margins.</p>","PeriodicalId":16200,"journal":{"name":"Journal of Investigative Surgery","volume":"38 1","pages":"2547226"},"PeriodicalIF":3.5,"publicationDate":"2025-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144957296","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Clinical and Microbial Features of Granulomatous Mastitis: Comparative Analysis of Breast and Gut Microbiota. 肉芽肿性乳腺炎的临床和微生物特征:乳腺和肠道微生物群的比较分析。
IF 3.5 4区 医学 Q2 SURGERY Pub Date : 2025-12-01 DOI: 10.1080/08941939.2025.2586015
Turgay Şimşek, Mehmet Fatih Özsaray, Sümeyye Şahin, Deniz Sünnetçi Akkoyunlu, Naci Çine, Nuh Zafer Cantürk

Background: Granulomatous mastitis (GM) is a rare benign inflammatory breast disease that may mimic carcinoma. Etiology remains unclear, but emerging evidence suggests a role for both breast and gut microbiota.

Methods: Between June 2022 and June 2024, 32 women with histopathology-confirmed GM and 44 non-GM controls (benign and non-granulomatous inflammatory conditions) were enrolled. Granulomatous tissue, adjacent normal breast tissue, and stool samples were collected. Microbiota composition was analyzed using 16S rRNA sequencing. Clinical variables were documented. Diversity analyses and receiver operating characteristic (ROC) curves assessed microbial differences and diagnostic potential.

Results: The GM cohort had a mean age of 36.8 years and BMI of 27.6 ± 3.9 kg/m2; 86.2% were postpartum, with no autoimmune or malignant conditions. GM lesions showed enrichment of Corynebacterium (notably C. kroppenstedtii), Staphylococcus, and Microbacterium, whereas Lactobacillus and Bifidobacterium were higher in normal tissue. Fecal samples exhibited reduced microbial diversity in GM compared with controls but did not replicate breast microbial profiles. ROC analysis indicated that Corynebacterium discriminated GM from controls with excellent accuracy (AUC = 0.87), while Staphylococcus was moderate (AUC = 0.78) and Lactobacillus inversely associated (AUC = 0.11).

Conclusions: GM demonstrates distinct microbial signatures, including pro-inflammatory taxa enrichment and protective commensal depletion, along with systemic dysbiosis. These findings support a microbiota-driven pathogenesis and highlight the potential of microbial biomarkers and therapeutic modulation.

背景:肉芽肿性乳腺炎(GM)是一种罕见的良性炎性乳腺疾病,可能与癌症相似。病因尚不清楚,但新出现的证据表明,乳房和肠道微生物群都有作用。方法:在2022年6月至2024年6月期间,招募了32名组织病理学证实的转基因女性和44名非转基因对照组(良性和非肉芽肿性炎症)。收集肉芽肿组织、邻近正常乳腺组织和粪便样本。采用16S rRNA测序分析菌群组成。记录临床变量。多样性分析和受试者工作特征(ROC)曲线评估了微生物差异和诊断潜力。结果:GM队列平均年龄36.8岁,BMI为27.6±3.9 kg/m2;86.2%为产后,无自身免疫性疾病或恶性疾病。转基因病变显示杆状杆菌(尤其是C. kroppenstedtii)、葡萄球菌和微细菌富集,而正常组织中乳酸杆菌和双歧杆菌含量较高。与对照组相比,转基因粪便样品的微生物多样性降低,但没有复制乳房微生物谱。ROC分析显示,棒状杆菌与对照组区分GM的准确度极好(AUC = 0.87),葡萄球菌与GM的准确度中等(AUC = 0.78),乳酸杆菌与GM的准确度呈负相关(AUC = 0.11)。结论:转基因表现出明显的微生物特征,包括促炎类群富集和保护性共生耗竭,以及全身生态失调。这些发现支持微生物群驱动的发病机制,并突出了微生物生物标志物和治疗调节的潜力。
{"title":"Clinical and Microbial Features of Granulomatous Mastitis: Comparative Analysis of Breast and Gut Microbiota.","authors":"Turgay Şimşek, Mehmet Fatih Özsaray, Sümeyye Şahin, Deniz Sünnetçi Akkoyunlu, Naci Çine, Nuh Zafer Cantürk","doi":"10.1080/08941939.2025.2586015","DOIUrl":"https://doi.org/10.1080/08941939.2025.2586015","url":null,"abstract":"<p><strong>Background: </strong>Granulomatous mastitis (GM) is a rare benign inflammatory breast disease that may mimic carcinoma. Etiology remains unclear, but emerging evidence suggests a role for both breast and gut microbiota.</p><p><strong>Methods: </strong>Between June 2022 and June 2024, 32 women with histopathology-confirmed GM and 44 non-GM controls (benign and non-granulomatous inflammatory conditions) were enrolled. Granulomatous tissue, adjacent normal breast tissue, and stool samples were collected. Microbiota composition was analyzed using 16S rRNA sequencing. Clinical variables were documented. Diversity analyses and receiver operating characteristic (ROC) curves assessed microbial differences and diagnostic potential.</p><p><strong>Results: </strong>The GM cohort had a mean age of 36.8 years and BMI of 27.6 ± 3.9 kg/m<sup>2</sup>; 86.2% were postpartum, with no autoimmune or malignant conditions. GM lesions showed enrichment of <i>Corynebacterium</i> (notably <i>C. kroppenstedtii</i>), <i>Staphylococcus</i>, and <i>Microbacterium</i>, whereas <i>Lactobacillus</i> and <i>Bifidobacterium</i> were higher in normal tissue. Fecal samples exhibited reduced microbial diversity in GM compared with controls but did not replicate breast microbial profiles. ROC analysis indicated that <i>Corynebacterium</i> discriminated GM from controls with excellent accuracy (AUC = 0.87), while <i>Staphylococcus</i> was moderate (AUC = 0.78) and <i>Lactobacillus</i> inversely associated (AUC = 0.11).</p><p><strong>Conclusions: </strong>GM demonstrates distinct microbial signatures, including pro-inflammatory taxa enrichment and protective commensal depletion, along with systemic dysbiosis. These findings support a microbiota-driven pathogenesis and highlight the potential of microbial biomarkers and therapeutic modulation.</p>","PeriodicalId":16200,"journal":{"name":"Journal of Investigative Surgery","volume":"38 1","pages":"2586015"},"PeriodicalIF":3.5,"publicationDate":"2025-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145648621","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Comparative Analysis of Postoperative Recovery and Analgesia in Gynecologic Laparoscopic Surgery with Total Intravenous Anesthesia Versus Combined Intravenous Inhalational Anesthesia Both with Ultrasound Guided Transversus Abdominis Plane Block: A Randomized Controlled Trial. 全静脉麻醉与超声引导下经腹平面阻滞联合静脉吸入麻醉对妇科腹腔镜手术术后恢复及镇痛的比较分析:一项随机对照试验。
IF 3.5 4区 医学 Q2 SURGERY Pub Date : 2025-12-01 Epub Date: 2025-12-11 DOI: 10.1080/08941939.2025.2594554
Wei Wang, Yong Tang, Yanqi Meng, Dingping Zhou, Jing Wang, Nijuan Li

Objective: This study aims to unravel the clinical effects of total intravenous anesthesia (TIVA) versus combined intravenous-inhalational anesthesia, each with ultrasound-guided transversus abdominis plane (TAP) block, in gynecologic laparoscopic surgery.

Methods: In this prospective randomized controlled trial, 100 patients undergoing gynecologic laparoscopic surgery were randomly assigned to either a control group (balanced inhalation anesthesia + TAP block) or an observation group (TIVA + TAP block) (n = 50 each). Postoperative recovery, pain scores (VAS at 2, 6, 12, 24, and 48 h), hemodynamics (SpO2, heart rate, SBP) at key surgical stages, and stress markers (cortisol, PGE2), and complications were recorded.

Results: Baseline characteristics were comparable. The observation group showed faster spontaneous respiration recovery, awakening, and extubation (all p < 0.05), though ambulation, flatus, and hospital stay did not differ (p > 0.05). VAS scores were lower in the observation group at all time points (p < 0.05). Hemodynamics remained stable in both groups. Postoperative cortisol and PGE2 rose in both groups but were lower in the observation group (p < 0.05). Nausea/vomiting incidence was reduced with TIVA (p < 0.05).

Conclusion: TIVA combined with ropivacaine TAP block accelerates early recovery, improves analgesia, attenuates surgical stress, and reduces nausea/vomiting.

目的:探讨超声引导下经腹平面(TAP)阻滞下全静脉麻醉(TIVA)与静脉-吸入联合麻醉在妇科腹腔镜手术中的临床效果。方法:本前瞻性随机对照试验将100例妇科腹腔镜手术患者随机分为对照组(平衡吸入麻醉+ TAP阻滞)和观察组(TIVA + TAP阻滞),各50例。记录术后恢复情况、疼痛评分(2、6、12、24和48小时的VAS)、关键手术阶段血流动力学(SpO2、心率、收缩压)、应激指标(皮质醇、PGE2)和并发症。结果:基线特征可比较。观察组患者自主呼吸恢复、苏醒、拔管均较快(p < 0.05)。观察组患者VAS评分在各时间点均较低(p < 0.05) (p < 0.05),但观察组患者VAS评分较低(p < 0.05)。结论:TIVA联合罗哌卡因TAP阻滞可加速患者早期恢复,改善镇痛,减轻手术应激,减轻恶心/呕吐。
{"title":"Comparative Analysis of Postoperative Recovery and Analgesia in Gynecologic Laparoscopic Surgery with Total Intravenous Anesthesia Versus Combined Intravenous Inhalational Anesthesia Both with Ultrasound Guided Transversus Abdominis Plane Block: A Randomized Controlled Trial.","authors":"Wei Wang, Yong Tang, Yanqi Meng, Dingping Zhou, Jing Wang, Nijuan Li","doi":"10.1080/08941939.2025.2594554","DOIUrl":"10.1080/08941939.2025.2594554","url":null,"abstract":"<p><strong>Objective: </strong>This study aims to unravel the clinical effects of total intravenous anesthesia (TIVA) versus combined intravenous-inhalational anesthesia, each with ultrasound-guided transversus abdominis plane (TAP) block, in gynecologic laparoscopic surgery.</p><p><strong>Methods: </strong>In this prospective randomized controlled trial, 100 patients undergoing gynecologic laparoscopic surgery were randomly assigned to either a control group (balanced inhalation anesthesia + TAP block) or an observation group (TIVA + TAP block) (<i>n</i> = 50 each). Postoperative recovery, pain scores (VAS at 2, 6, 12, 24, and 48 h), hemodynamics (SpO<sub>2</sub>, heart rate, SBP) at key surgical stages, and stress markers (cortisol, PGE<sub>2</sub>), and complications were recorded.</p><p><strong>Results: </strong>Baseline characteristics were comparable. The observation group showed faster spontaneous respiration recovery, awakening, and extubation (all <i>p</i> < 0.05), though ambulation, flatus, and hospital stay did not differ (<i>p</i> > 0.05). VAS scores were lower in the observation group at all time points (<i>p</i> < 0.05). Hemodynamics remained stable in both groups. Postoperative cortisol and PGE<sub>2</sub> rose in both groups but were lower in the observation group (<i>p</i> < 0.05). Nausea/vomiting incidence was reduced with TIVA (<i>p</i> < 0.05).</p><p><strong>Conclusion: </strong>TIVA combined with ropivacaine TAP block accelerates early recovery, improves analgesia, attenuates surgical stress, and reduces nausea/vomiting.</p>","PeriodicalId":16200,"journal":{"name":"Journal of Investigative Surgery","volume":"38 1","pages":"2594554"},"PeriodicalIF":3.5,"publicationDate":"2025-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145723638","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Efficacy and Safety of Radiofrequency Ablation for Papillary Thyroid Cancer: A Systematic Review and Meta-Analysis. 射频消融治疗甲状腺乳头状癌的疗效和安全性:一项系统综述和荟萃分析。
IF 3.5 4区 医学 Q2 SURGERY Pub Date : 2025-12-01 Epub Date: 2025-09-29 DOI: 10.1080/08941939.2025.2562263
Jiuxi Wu, Jian Wang, Jun Gao

Objective: This systematic review and meta-analysis aimed to evaluate the efficacy and safety of radiofrequency ablation (RFA) in the management of papillary thyroid cancer (PTC).

Methods: A comprehensive literature search was conducted in the PubMed, Embase, Cochrane Library, Web of Science and CNKI databases. Studies reporting outcomes of RFA for PTC were included. Random-effects models were used for meta-analysis, and heterogeneity was assessed using I2 statistics.

Results: Fifteen retrospective studies involving 1,844 patients were included. The meta-analysis revealed a pooled standardized mean difference of -1.11 (95% CI: -1.39 to -0.84) for volume reduction at 12 months, corresponding to an approximate 88.9% mean volume reduction, with moderate heterogeneity (I2 = 55.4%). The pooled risk ratio (RR) for complete disappearance was 1.08 (95% CI: 0.99-1.18), with significant heterogeneity among studies (I2 = 71.4%). The local recurrence rate was 0.62% (95% CI: 0.32%-1.21%), with no significant heterogeneity (I2 = 0.0%). The RFS analysis showed a pooled RR of 1.00 (95% CI: 0.93-1.08), with no significant heterogeneity (I2 = 0.0%). The local tumor progression rate was 1.42% (95% CI: 0.81%-2.48%), also with no significant heterogeneity (I2 = 0.0%).

Conclusion: This meta-analysis suggests that RFA is an effective and safe treatment for PTC, demonstrating high volume reduction rates, satisfactory complete disappearance rates and low local recurrence rates.

目的:本系统综述和荟萃分析旨在评价射频消融(RFA)治疗甲状腺乳头状癌(PTC)的有效性和安全性。方法:在PubMed、Embase、Cochrane Library、Web of Science和CNKI数据库中进行综合文献检索。研究报告了RFA治疗PTC的结果。采用随机效应模型进行meta分析,采用I2统计量评估异质性。结果:纳入15项回顾性研究,涉及1844例患者。荟萃分析显示,12个月时体积缩小的合并标准化平均差异为-1.11 (95% CI: -1.39至-0.84),对应于大约88.9%的平均体积缩小,具有中等异质性(I2 = 55.4%)。完全消失的合并风险比(RR)为1.08 (95% CI: 0.99-1.18),研究间存在显著异质性(I2 = 71.4%)。局部复发率为0.62% (95% CI: 0.32% ~ 1.21%),无显著异质性(I2 = 0.0%)。RFS分析显示,合并RR为1.00 (95% CI: 0.93-1.08),无显著异质性(I2 = 0.0%)。局部肿瘤进展率为1.42% (95% CI: 0.81% ~ 2.48%),也无显著异质性(I2 = 0.0%)。结论:本荟萃分析表明RFA治疗PTC有效且安全,具有高体积缩小率,令人满意的完全消失率和低局部复发率。
{"title":"Efficacy and Safety of Radiofrequency Ablation for Papillary Thyroid Cancer: A Systematic Review and Meta-Analysis.","authors":"Jiuxi Wu, Jian Wang, Jun Gao","doi":"10.1080/08941939.2025.2562263","DOIUrl":"10.1080/08941939.2025.2562263","url":null,"abstract":"<p><strong>Objective: </strong>This systematic review and meta-analysis aimed to evaluate the efficacy and safety of radiofrequency ablation (RFA) in the management of papillary thyroid cancer (PTC).</p><p><strong>Methods: </strong>A comprehensive literature search was conducted in the PubMed, Embase, Cochrane Library, Web of Science and CNKI databases. Studies reporting outcomes of RFA for PTC were included. Random-effects models were used for meta-analysis, and heterogeneity was assessed using I<sup>2</sup> statistics.</p><p><strong>Results: </strong>Fifteen retrospective studies involving 1,844 patients were included. The meta-analysis revealed a pooled standardized mean difference of -1.11 (95% CI: -1.39 to -0.84) for volume reduction at 12 months, corresponding to an approximate 88.9% mean volume reduction, with moderate heterogeneity (I<sup>2</sup> = 55.4%). The pooled risk ratio (RR) for complete disappearance was 1.08 (95% CI: 0.99-1.18), with significant heterogeneity among studies (I<sup>2</sup> = 71.4%). The local recurrence rate was 0.62% (95% CI: 0.32%-1.21%), with no significant heterogeneity (I<sup>2</sup> = 0.0%). The RFS analysis showed a pooled RR of 1.00 (95% CI: 0.93-1.08), with no significant heterogeneity (I<sup>2</sup> = 0.0%). The local tumor progression rate was 1.42% (95% CI: 0.81%-2.48%), also with no significant heterogeneity (I<sup>2</sup> = 0.0%).</p><p><strong>Conclusion: </strong>This meta-analysis suggests that RFA is an effective and safe treatment for PTC, demonstrating high volume reduction rates, satisfactory complete disappearance rates and low local recurrence rates.</p>","PeriodicalId":16200,"journal":{"name":"Journal of Investigative Surgery","volume":"38 1","pages":"2562263"},"PeriodicalIF":3.5,"publicationDate":"2025-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145191708","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Regarding: "Enhancing Outcomes in Transarterial Embolization for Late Postpancreatectomy Hemorrhage: A Comparison of N-Butyl Cyanoacrylate with Mixed Embolic Agents Versus Mixed Embolic Agents Alone". 关于:“提高经动脉栓塞治疗晚期胰腺切除术后出血的疗效:氰基丙烯酸丁酯与混合栓塞剂与单独混合栓塞剂的比较”。
IF 3.5 4区 医学 Q2 SURGERY Pub Date : 2025-12-01 Epub Date: 2025-10-20 DOI: 10.1080/08941939.2025.2574612
Romaric Loffroy
{"title":"Regarding: \"Enhancing Outcomes in Transarterial Embolization for Late Postpancreatectomy Hemorrhage: A Comparison of N-Butyl Cyanoacrylate with Mixed Embolic Agents Versus Mixed Embolic Agents Alone\".","authors":"Romaric Loffroy","doi":"10.1080/08941939.2025.2574612","DOIUrl":"https://doi.org/10.1080/08941939.2025.2574612","url":null,"abstract":"","PeriodicalId":16200,"journal":{"name":"Journal of Investigative Surgery","volume":"38 1","pages":"2574612"},"PeriodicalIF":3.5,"publicationDate":"2025-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145329287","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The Influence of Growth Blocking of the Neurocentral Cartilages on the Development of the Spinal Canal. An Experimental Study in Pigs. 神经中枢软骨生长阻滞对椎管发育的影响。猪的实验研究。
IF 3.5 4区 医学 Q2 SURGERY Pub Date : 2025-12-01 Epub Date: 2025-11-20 DOI: 10.1080/08941939.2025.2586016
Rafael Llombart-Ais, Rafael Llombart-Blanco, Gonzalo Mariscal, María Benlloch, Carlos Barrios, José Luis Beguiristáin

Background: The neurocentral cartilage (NCC) is crucial for vertebral development and spinal canal shape, with its peak activity occurring around ages 5-6. The objective of this experimental animal study was to investigate whether bilateral epiphysiodesis of the NCC using pedicle screws can induce spinal canal narrowing in the thoracolumbar spine.

Methods: Twenty-four domestic pigs were divided into four groups based on the level of NCC blockage: low thoracic, thoracolumbar transitional hinge, upper lumbar spine, and caudal lumbar levels below L5. The animals were monitored for 8-9 months, during which morphological, morphometric, and radiological parameters were analyzed and compared to those of 14 control pigs.

Results: No asymmetrical growth or coronal deformities were observed (p > 0.05). NCC caused a significant reduction in sagittal pedicle length (-2.94 mm, 32.6%) in lower lumbar segments (L3-L6) and a 3.11 mm (29.6%) decrease in the anteroposterior canal diameter, leading to segmental stenosis most pronounced caudally. The transverse diameter of the canal remained largely unchanged. Morphologically, slight lumbar hyper lordosis and compensatory thoracic kyphosis were observed.

Conclusions: Symmetrical NCC growth arrest using pedicle screws induces spinal canal narrowing through decreased sagittal diameter, linked to insufficient development of vertebral pedicles. These findings suggest caution in employing thoracolumbar pedicle screws in skeletally immature patients with an open NCC.

背景:神经中枢软骨(NCC)对椎体发育和椎管形状至关重要,其活动高峰发生在5-6岁左右。本实验动物研究的目的是探讨使用椎弓根螺钉对NCC进行双侧表皮成形术是否会导致胸腰椎椎管狭窄。方法:24头家猪根据NCC阻塞程度分为4组:低胸段、胸腰椎过渡铰链段、上腰椎段和L5以下腰尾段。对这些猪进行8-9个月的监测,在此期间分析形态学、形态计量学和放射学参数,并与14头对照猪进行比较。结果:未见不对称生长及冠状畸形(p < 0.05)。NCC导致下腰椎节段(L3-L6)矢状椎弓根长度显著减少(-2.94 mm, 32.6%),前后椎管直径减少3.11 mm(29.6%),导致节段狭窄最明显的尾部。运河的横向直径基本保持不变。形态学上观察到轻度腰椎前凸过度和代偿性胸后凸。结论:椎弓根螺钉用于对称型NCC生长抑制,通过减小矢状直径导致椎管狭窄,与椎弓根发育不足有关。这些结果提示,对于开放性NCC的未成熟骨患者,应谨慎使用胸腰椎椎弓根螺钉。
{"title":"The Influence of Growth Blocking of the Neurocentral Cartilages on the Development of the Spinal Canal. An Experimental Study in Pigs.","authors":"Rafael Llombart-Ais, Rafael Llombart-Blanco, Gonzalo Mariscal, María Benlloch, Carlos Barrios, José Luis Beguiristáin","doi":"10.1080/08941939.2025.2586016","DOIUrl":"https://doi.org/10.1080/08941939.2025.2586016","url":null,"abstract":"<p><strong>Background: </strong>The neurocentral cartilage (NCC) is crucial for vertebral development and spinal canal shape, with its peak activity occurring around ages 5-6. The objective of this experimental animal study was to investigate whether bilateral epiphysiodesis of the NCC using pedicle screws can induce spinal canal narrowing in the thoracolumbar spine.</p><p><strong>Methods: </strong>Twenty-four domestic pigs were divided into four groups based on the level of NCC blockage: low thoracic, thoracolumbar transitional hinge, upper lumbar spine, and caudal lumbar levels below L5. The animals were monitored for 8-9 months, during which morphological, morphometric, and radiological parameters were analyzed and compared to those of 14 control pigs.</p><p><strong>Results: </strong>No asymmetrical growth or coronal deformities were observed (<i>p</i> > 0.05). NCC caused a significant reduction in sagittal pedicle length (-2.94 mm, 32.6%) in lower lumbar segments (L<sub>3</sub>-L<sub>6</sub>) and a 3.11 mm (29.6%) decrease in the anteroposterior canal diameter, leading to segmental stenosis most pronounced caudally. The transverse diameter of the canal remained largely unchanged. Morphologically, slight lumbar hyper lordosis and compensatory thoracic kyphosis were observed.</p><p><strong>Conclusions: </strong>Symmetrical NCC growth arrest using pedicle screws induces spinal canal narrowing through decreased sagittal diameter, linked to insufficient development of vertebral pedicles. These findings suggest caution in employing thoracolumbar pedicle screws in skeletally immature patients with an open NCC.</p>","PeriodicalId":16200,"journal":{"name":"Journal of Investigative Surgery","volume":"38 1","pages":"2586016"},"PeriodicalIF":3.5,"publicationDate":"2025-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145557078","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Journal of Investigative Surgery
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1